Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diversity
Research
NIH grant cuts hit women, early-career scientists the hardest
At the time of last year's grant cancellations and funding freezes, 57.9% of active projects were led by women, compared to 48.2% led by men.
Darren Incorvaia
Mar 23, 2026 3:00pm
Building BLOC: Meet Biopharma Leaders of Color
Mar 12, 2026 10:00am
Fierce Pharma
2025's Fiercest Women in Life Sciences
Nov 17, 2025 3:00am
As 2 CEOs depart, life sciences face leadership void for women
Oct 3, 2025 11:22am
Fierce Pharma
Nominations open for Fiercest Women in Life Sciences—LAST DAY
Sep 26, 2025 7:00am
Supreme Court reverses lower court ruling, allows NIH grant cuts
Aug 22, 2025 11:22am